
India's single-specialty healthcare market is projected to grow at a 22% annual rate, reaching $12.3 billion by 2030, driven by focused providers offering repeatable care with higher clinical specialization. Bessemer Venture Partners has invested in companies like NephroPlus, Pluro, and Sukino, aiming to build national platforms through scalable, asset-light models. This shift complements multi-specialty hospitals and may lead to new IPOs and acquisitions as category leaders emerge.
Select a news story to see related coverage from other media outlets.